Literature DB >> 10924137

The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution.

D C Haines1, I F Sevrioukova, J A Peterson.   

Abstract

Cytochrome P450BM-3 is a self-sufficient bacterial protein containing three naturally fused domains which bind either heme, FMN, or FAD. Resolution of protein and FMN from the isolated FMN-containing domain of cytochrome P450Betamicro-3 was accomplished using trichloroacetic acid. The apoprotein thus prepared was shown to rebind FMN to regenerate the original holoprotein as indicated by both spectroscopy and activity measurements. To better understand how the protein/flavin interaction might contribute to reactivity, the association process was studied in detail. Fluorescence quenching was used to measure a dissociation constant of the flavin-protein complex of 31 nM, comparable to FMN-containing proteins of similar reactivity and higher than that of flavodoxins. Stopped-flow kinetics were performed, and a multistep binding process was indicated, with an initial k(on) value of 1.72 x 10(5) M(-)(1) s(-)(1). Preparation of the apoprotein allowed substitution of flavin analogues for the native FMN cofactor using 8-chloro-FMN and 8-amino-FMN. Both were found to bind efficiently to the protein with only minor variations in affinity. Reductive titrations established that, as in the native FMN-containing FMN-binding domain, the 8-amino-FMN-substituted domain does not produce a stable one-electron-reduced species during titration with sodium dithionite. The 8-chloro-FMN-substituted domain, however, had sufficiently altered redox properties to form a stable red anionic semiquinone. The 8-chloro-FMN-substituted FMN-binding domain was shown in reconstituted systems to retain most of the cytochrome c reductase activity of the native domain but only a very small amount of palmitic acid hydroxylase activity. The 8-amino-FMN-substituted FMN-binding domain showed no palmitic acid hydroxylase activity and only 30% of the native cytochrome c reductase activity, demonstrating the importance of thermodynamics to the mechanism of this protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924137     DOI: 10.1021/bi000255p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Thermal inactivation of the reductase domain of cytochrome P450 BM3.

Authors:  Arvind P Jamakhandi; Brandon C Jeffus; Vandana R Dass; Grover P Miller
Journal:  Arch Biochem Biophys       Date:  2005-07-15       Impact factor: 4.013

2.  Synthesis and application of isotopically labeled flavin nucleotides.

Authors:  Tatiana V Mishanina; Amnon Kohen
Journal:  J Labelled Comp Radiopharm       Date:  2015-07-07       Impact factor: 1.921

3.  A single active-site mutation of P450BM-3 dramatically enhances substrate binding and rate of product formation.

Authors:  Donovan C Haines; Amita Hegde; Baozhi Chen; Weiqiang Zhao; Muralidhar Bondlela; John M Humphreys; David A Mullin; Diana R Tomchick; Mischa Machius; Julian A Peterson
Journal:  Biochemistry       Date:  2011-09-06       Impact factor: 3.162

4.  Chain length-dependent cooperativity in fatty acid binding and oxidation by cytochrome P450BM3 (CYP102A1).

Authors:  Benjamin Rowlatt; Jake A Yorke; Anthony J Strong; Christopher J C Whitehouse; Stephen G Bell; Luet-Lok Wong
Journal:  Protein Cell       Date:  2011-09-09       Impact factor: 14.870

5.  Functional characterization of the re-face loop spanning residues 536-541 and its interactions with the cofactor in the flavin mononucleotide-binding domain of flavocytochrome P450 from Bacillus megaterium.

Authors:  Mumtaz Kasim; Huai-Chun Chen; Richard P Swenson
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

6.  Flavin homeostasis in the mouse retina during aging and degeneration.

Authors:  Tirthankar Sinha; Mustafa Makia; Jianhai Du; Muna I Naash; Muayyad R Al-Ubaidi
Journal:  J Nutr Biochem       Date:  2018-09-15       Impact factor: 6.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.